These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 10022126

  • 1. Decreased expression of the pro-apoptotic protein Par-4 in renal cell carcinoma.
    Cook J, Krishnan S, Ananth S, Sells SF, Shi Y, Walther MM, Linehan WM, Sukhatme VP, Weinstein MH, Rangnekar VM.
    Oncogene; 1999 Feb 04; 18(5):1205-8. PubMed ID: 10022126
    [Abstract] [Full Text] [Related]

  • 2. Ectopic expression of Par-4 leads to induction of apoptosis in CNS tumor cell lines.
    Vetterkind S, Boosen M, Scheidtmann KH, Preuss U.
    Int J Oncol; 2005 Jan 04; 26(1):159-67. PubMed ID: 15586236
    [Abstract] [Full Text] [Related]

  • 3. Induction and regulation of tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand-mediated apoptosis in renal cell carcinoma.
    Griffith TS, Fialkov JM, Scott DL, Azuhata T, Williams RD, Wall NR, Altieri DC, Sandler AD.
    Cancer Res; 2002 Jun 01; 62(11):3093-9. PubMed ID: 12036919
    [Abstract] [Full Text] [Related]

  • 4. NF-kappa B does not modulate sensitivity of renal carcinoma cells to TNF alpha-related apoptosis-inducing ligand (TRAIL).
    Pawlowski JE, Nesterov A, Scheinman RI, Johnson TR, Kraft AS.
    Anticancer Res; 2000 Jun 01; 20(6B):4243-55. PubMed ID: 11205254
    [Abstract] [Full Text] [Related]

  • 5. Mutually exclusive expression patterns of Bcl-2 and Par-4 in human prostate tumors consistent with down-regulation of Bcl-2 by Par-4.
    Qiu G, Ahmed M, Sells SF, Mohiuddin M, Weinstein MH, Rangnekar VM.
    Oncogene; 1999 Jan 21; 18(3):623-31. PubMed ID: 9989812
    [Abstract] [Full Text] [Related]

  • 6. Immunohistochemical analysis of the proapoptotic protein Par-4 in normal rat tissues.
    Boghaert ER, Sells SF, Walid AJ, Malone P, Williams NM, Weinstein MH, Strange R, Rangnekar VM.
    Cell Growth Differ; 1997 Aug 21; 8(8):881-90. PubMed ID: 9269897
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Differential induction of apoptosis by tumor necrosis factor-related apoptosis-inducing ligand in human ovarian carcinoma cells.
    Lane D, Cartier A, L'Espérance S, Côté M, Rancourt C, Piché A.
    Gynecol Oncol; 2004 Jun 21; 93(3):594-604. PubMed ID: 15196850
    [Abstract] [Full Text] [Related]

  • 10. Decreased expression of the human stem cell marker, Rex-1 (zfp-42), in renal cell carcinoma.
    Raman JD, Mongan NP, Liu L, Tickoo SK, Nanus DM, Scherr DS, Gudas LJ.
    Carcinogenesis; 2006 Mar 21; 27(3):499-507. PubMed ID: 16344273
    [Abstract] [Full Text] [Related]

  • 11. Downregulation of Smac/DIABLO expression in renal cell carcinoma and its prognostic significance.
    Mizutani Y, Nakanishi H, Yamamoto K, Li YN, Matsubara H, Mikami K, Okihara K, Kawauchi A, Bonavida B, Miki T.
    J Clin Oncol; 2005 Jan 20; 23(3):448-54. PubMed ID: 15572731
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of human melanoma is regulated by smac/DIABLO release from mitochondria.
    Zhang XD, Zhang XY, Gray CP, Nguyen T, Hersey P.
    Cancer Res; 2001 Oct 01; 61(19):7339-48. PubMed ID: 11585775
    [Abstract] [Full Text] [Related]

  • 14. Expression of apoptotic tumour necrosis factor receptor-associated factor, caspase recruitment domain and cell death-inducing DFF-45 effector genes in therapy-treated renal cell carcinoma.
    Rajandram R, Pat BK, Li J, Johnson DW, Gobe GC.
    Nephrology (Carlton); 2009 Apr 01; 14(2):205-12. PubMed ID: 19076291
    [Abstract] [Full Text] [Related]

  • 15. Prostate apoptosis response gene-4 (par-4) abrogates the survival function of p185(BCR-ABL) in hematopoietic cells.
    Kukoc-Zivojnov N, Puccetti E, Chow KU, Bergmann M, Ruthardt M, Hoelzer D, Mitrou PS, Weidmann E, Boehrer S.
    Exp Hematol; 2004 Jul 01; 32(7):649-56. PubMed ID: 15246161
    [Abstract] [Full Text] [Related]

  • 16. Over-expression of Smac promotes TRAIL-induced cell death in human hepatocellular carcinoma.
    Okano H, Shiraki K, Inoue H, Kawakita T, Saitou Y, Enokimura N, Yamamoto N, Sugimoto K, Fujikawa K, Murata K, Nakano T.
    Int J Mol Med; 2003 Jul 01; 12(1):25-8. PubMed ID: 12792804
    [Abstract] [Full Text] [Related]

  • 17. Chemotherapeutic agents augment TRAIL-induced apoptosis in human hepatocellular carcinoma cell lines.
    Yamanaka T, Shiraki K, Sugimoto K, Ito T, Fujikawa K, Ito M, Takase K, Moriyama M, Nakano T, Suzuki A.
    Hepatology; 2000 Sep 01; 32(3):482-90. PubMed ID: 10960439
    [Abstract] [Full Text] [Related]

  • 18. Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas.
    Herr I, Ucur E, Herzer K, Okouoyo S, Ridder R, Krammer PH, von Knebel Doeberitz M, Debatin KM.
    Cancer Res; 2003 Jun 15; 63(12):3112-20. PubMed ID: 12810637
    [Abstract] [Full Text] [Related]

  • 19. Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5.
    Mitsiades N, Poulaki V, Mitsiades C, Tsokos M.
    Cancer Res; 2001 Mar 15; 61(6):2704-12. PubMed ID: 11289151
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.